Vita, Emanuele
 Distribuzione geografica
Continente #
AS - Asia 883
NA - Nord America 873
EU - Europa 578
SA - Sud America 219
AF - Africa 27
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.584
Nazione #
US - Stati Uniti d'America 828
SG - Singapore 401
CN - Cina 180
BR - Brasile 178
IT - Italia 155
SE - Svezia 104
VN - Vietnam 100
DE - Germania 67
FR - Francia 56
IN - India 49
GB - Regno Unito 39
FI - Finlandia 28
AR - Argentina 23
JP - Giappone 22
ID - Indonesia 21
CA - Canada 20
HK - Hong Kong 20
NL - Olanda 20
IE - Irlanda 18
KR - Corea 17
MX - Messico 16
RU - Federazione Russa 15
AT - Austria 13
BD - Bangladesh 13
TR - Turchia 13
IQ - Iraq 12
PL - Polonia 12
CZ - Repubblica Ceca 10
ES - Italia 8
ZA - Sudafrica 8
EC - Ecuador 7
UA - Ucraina 7
LT - Lituania 6
CO - Colombia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CI - Costa d'Avorio 4
JO - Giordania 4
TN - Tunisia 4
AL - Albania 3
IR - Iran 3
UZ - Uzbekistan 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
RO - Romania 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
ML - Mali 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 2.584
Città #
Singapore 247
Ashburn 123
San Jose 86
Chandler 56
New York 52
Rome 52
Hefei 39
Ho Chi Minh City 39
Hyderabad 35
Los Angeles 35
The Dalles 32
Council Bluffs 27
Beijing 26
Hanoi 23
Milan 22
Tokyo 22
Frankfurt am Main 20
St Louis 20
Lauterbourg 19
São Paulo 19
Dallas 18
Dublin 18
Hong Kong 18
Jakarta 17
Munich 17
Cattolica 16
Seoul 16
Boardman 14
Helsinki 13
Santa Clara 13
Buffalo 12
Kent 11
Orem 11
Brno 9
Chicago 9
Paris 9
Turku 9
Brooklyn 8
Düsseldorf 8
Moscow 8
Vienna 8
Warsaw 8
Atlanta 7
Boston 7
Denver 7
Montreal 7
San Mateo 7
Stockholm 7
Amsterdam 6
Bexley 6
Bremen 6
Da Nang 6
Des Moines 6
Lappeenranta 6
Phoenix 6
Poplar 6
Princeton 6
Johannesburg 5
London 5
Marseille 5
Quito 5
Abidjan 4
Amman 4
Baghdad 4
Brussels 4
Falkenstein 4
Goiânia 4
Guangzhou 4
Haiphong 4
Madrid 4
Mexico City 4
Middlesbrough 4
North Bergen 4
Nuremberg 4
Odesa 4
Orangeburg 4
Portsmouth 4
Riyadh 4
Toronto 4
Wroclaw 4
Ankara 3
Bắc Ninh 3
Campinas 3
Charlotte 3
Chennai 3
Cuiabá 3
Erbil 3
Fairfield 3
Houston 3
Huzhou 3
Manaus 3
Manchester 3
Ottawa 3
Petrozavodsk 3
Piracicaba 3
Querétaro 3
Santo André 3
Seattle 3
Starnberg 3
Wilmington 3
Totale 1.516
Nome #
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 170
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 168
From palliation to cure: PIPAC for peritoneal malignancies 151
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 139
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 133
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 133
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 132
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 131
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 128
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 124
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 116
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 115
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 110
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 109
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 106
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 105
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 103
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review 102
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 102
Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis 93
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 81
Surgery after induction chemo or immunotherapy for locally advanced NSCLC 74
Totale 2.625
Categoria #
all - tutte 9.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 4 10 1
2021/202272 20 0 1 14 1 1 0 8 2 2 8 15
2022/2023157 21 20 13 27 9 23 11 8 18 0 2 5
2023/2024203 3 35 9 10 8 18 26 9 2 21 21 41
2024/2025679 23 6 41 34 42 30 32 20 85 109 146 111
2025/20261.491 180 78 110 259 295 69 215 83 114 88 0 0
Totale 2.625